We calculated the magnitude of various serum pharmacodynamic parameters for fluoroquinolones in models of experimental endocarditis (EE) described in the literature. Nineteen publications contained data that allowed calculation of these parameters. Data were available for eight fluoroquinolones against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus, methicillin-resistant Staphylococcus epidermidis, viridans streptococci, Enterobacter aerogenes, and Pseudomonas aeruginosa in rabbit or rat models. Enterococci were excluded because of poor bactericidal activity. A 24-hour area under the concentration curve (AUC)/ minimal inhibitory concentration (MIC) ratio §100, a peak level/MIC ratio ú8, and continuous levels above the time were associated with a significantly lower number of cfu per vegetation after 3 -6 days of therapy. The 24-hour AUC/MIC exhibited the best linear correlation with cfu per vegetation after 3 -6 days of therapy (r 2 Å 45%). The pharmacodynamic parameters predictive of efficacy for fluoroquinolones in the treatment of experimental endocarditis are similar to those for other infectious models.
Previous observations regarding the murine thigh infecKinetics data from the available studies were used to calculate the peak serum level/MIC, the 24-hour AUC/MIC, tion model have demonstrated that the primary pharmacodyand the time above the MIC for each dosing regimen. In namic parameter correlating with therapeutic efficacy of vivo efficacy was determined in each study by a count of fluoroquinolone antibiotics is the area under the concentracfu per vegetation at the end of 3 -6 days of therapy. Bactetion curve (AUC)/MIC [1, 2] . Thus, it is the total amount rial colony counts from these data were correlated with each of drug, rather than the dosing regimen, that determines the of the above pharmacokinetic/pharmacodynamic parameters in vivo potency of fluoroquinolones. We proposed that this by using linear regression analysis to determine which paobservation is independent of the animal used or the site of rameter was associated with greatest efficacy. For statistical infection.
calculations we used r 2 to estimate the fraction of total variThe goal of our investigation was to review data from pubance in antimicrobial effect that could be attributed to its lished studies of experimental endocarditis (EE) that included linear regression with each pharmacodynamic parameter. both the pharmacokinetics and pharmacodynamics of the fluMann-Whitney U tests were used to compare efficacy by oroquinolone therapies used. With these data, we calculated pharmacokinetic groups. several pharmacodynamic parameters, including 24-hour AUC/ Our literature search identified 19 publications on EE in MIC, peak level/MIC, and time above MIC. We then compared either the rabbit or rat model [3 -21] . In these studies, data were the magnitude of these pharmacodynamic parameters with the available for eight fluoroquinolones (ciprofloxacin, fleroxacin, number of bacteria recovered in vegetations after 3 -6 days of sparfloxacin, levofloxacin, temafloxacin, pefloxacin, enoxacin, therapy to determine which parameters correlated with greatest and Cl-960) against six types of organisms (methicillin-suscepefficacy.
tible Staphylococcus aureus, methicillin-resistant S. aureus, A MEDLINE search was performed to locate studies of EE methicillin-resistant Staphylococcus epidermidis, viridans in which fluoroquinolones were used as therapy. Studies were streptococci, Enterobacter aerogenes, and Pseudomonas aeruexcluded (1) if the duration of antibiotic therapy was õ48 ginosa) in two animal models, the rabbit or the rat. Therapeutic hours, (2) no pharmacokinetics were described, and (3) minimal regimens included a single dosing interval per study -either killing was exhibited for the organism tested when antibiotics 6, 8, or 12 hours. From these studies 35 data points met our were used alone (e.g., enterococci).
criteria for 24-hour AUC/MIC and time above MIC, and 37 data points met our criteria for peak level/MIC. Efficacy was ranged from 10.8 to 780, the peak level/MIC ratios ranged from 1.76 to 129, and time above MIC ranged from 27% -100%.
The correlations between various pharmacodynamic parameters and efficacy (i.e., log 10 cfu per vegetation) are shown in figures 1 -3. All three parameters had very similar correlations with efficacy. The AUC/MIC ratio had the highest r 2 value (45%), followed closely by time above MIC (43%) and then peak level/MIC (40.8%). The high correlation with all three parameters reflects the strong interrelationship between parameters when only one dosing frequency is used.
The mean values and range for cfu per vegetation among the different groups are shown in table 2. A 24-hour AUC/ MIC §100, peak level/MIC ú8, and serum levels above the MIC 100% of the time were associated with significantly lower numbers of cfu per vegetation after 3 -6 days of using linear regression analysis.
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